Preclinical

AstraZeneca opens new advanced therapeutics R&D facility in Cambridge

23-Nov-2021 By Jane Byrne

AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.

Industry veteran commits to improved patient solutions at CTMA

08-Nov-2021 By Jenni Spinner

After 30 years’ experience, including stints advising top pharma firms, the expert has joined a firm offering tech aimed at elevating patient ID and enrollment.

Digital Medicine Society brings pharma firms together on new digital endpoint

02-Nov-2021 By Jenni Spinner

The group is collaborating with AbbVie, Janssen, Novartis, Pfizer, and UCB to help advance nocturnal scratch as a digital endpoint for atopic dermatitis.

Protodigm collaborates with research institute on heart disease dataset

02-Nov-2021 By Jenni Spinner

The company is joining with the Thrombosis Research Institute on the creation of a heart disease patient dataset to advance precision medicine development.

Global Genes partners to elevate equity for rare disease patients

25-Oct-2021 By Jenni Spinner

The advocacy group is joining with the Rare Disease Diversity Coalition on an initiative to identify and overcome challenges faced by minority patients.

RWD from community registries adds long COVID understanding: IQVIA

25-Oct-2021 By Jenni Spinner

An epidemiologist from the healthcare data specialist offers perspective on how real-world data can help get to the heart of long-lasting COVID research.

UCI, Syntropy join forces on research/care data project

19-Oct-2021 By Jenni Spinner

The University of California at Irvine and the data firm will work on solutions that help integrate health data for both clinical trials and patient care.

COVID-19 lessons can apply to hepatitis treatments: Phesi

18-Oct-2021 By Jenni Spinner

According to the firm, infectious-disease research advancements could be applied to discovering treatments for millions of hepatitis patients globally.

AI-powered data specialist ScienceIO announces official launch

14-Oct-2021 By Jenni Spinner

The company has deployed with several healthcare firms, emerged from stealth, named a chief commercial officer, and landed investors backing the technology.

AAPS PharmSci 360

PharmSci 360 invites industry pros to ‘rethink and evolve’

14-Oct-2021 By Jenni Spinner

The conference (with online and in-person content) is slated to gather professionals for deep conversations and lively collaboration on important topics.

‘Progress does not happen overnight’: Sanofi on evolution of medicine

14-Oct-2021 By Jenni Spinner

A leader from the pharmaceutical firm talks about some of the most impactful technologies and shares a number of notable advancements made by the company.

CDC turns to PointClickCare to gain insights from patient data

12-Oct-2021 By Jenni Spinner

The US agency plans to use the software firm’s Lighthouse technology to improve understanding of COVID-19 and other conditions in long-term care facilities.

CytoReason, Summit tap into AI on Japanese drug development effort

12-Oct-2021 By Jenni Spinner

The AI technology firm and pharma services company are joining to help one of the country’s leading pharmaceutical firms develop a promising drug candidate.

Mastering data management can lead to improved outcomes: CitiusTech

11-Oct-2021 By Jenni Spinner

According to two leaders from the healthcare tech firm, improving the way healthcare data is collected, stored, and used can contribute to improved care.

Metrics make a difference in clinical research advancement: Advarra

07-Oct-2021 By Jenni Spinner

An expert from the IRB and study solutions firm explains how advanced analytics can lead to several benefits, including shortened trial startup timelines.

People on the Move: October 2021

07-Oct-2021 By Jenni Spinner

This month’s news on appointments, expansions, acquisitions and other events includes Nanoform, Elligo Health Research, Curavit, and other organizations.

Informatics useful in advancing personalized medicine: Washington University

05-Oct-2021 By Jenni Spinner

A representative from the school explains how tools like artificial intelligence and natural language processing can help elevate personalized medicine.

Making the most of trial data can benefit patients: Parexel

05-Oct-2021 By Jenni Spinner

An expert from the CRO explains the evolution of data technologies put to use in clinical studies and offers advice on how to best make them work in trials.

Patients want to see more health industry collaboration: survey

30-Sep-2021 By Jenni Spinner

A study by Charles River finds patients believe the overall quality of healthcare would increase if stakeholders across the life sciences collaborated more.

Merck to acquire Acceleron Pharma, strengthening cardiovascular pipeline

30-Sep-2021 By Rachel Arthur

Merck (MSD outside the US and Canada) will acquire Acceleron in a deal worth around $11.5bn.

Real-world data use in trials can yield real benefits: Firma

27-Sep-2021 By Jenni Spinner

A leader from Firma Clinical Research advises that while using RWD can be daunting, putting the data to use can lead to a number of notable advantages.

Rare-disease initiative collaborators work to advance research innovation

16-Sep-2021 By Jenni Spinner

Stakeholders in the Rare Disease Cures Accelerator-Data and Analytics Platform initiative are partnering in hopes of bringing treatments to patients faster.

Tech Innovations: September 2021

16-Sep-2021 By Jenni Spinner

This month’s roundup of new technology, equipment, and industry partnerships includes news from IBM, IQVIA, Mediata, Labcorp, and other notable companies.

Gates Foundation, Exscientia enter $70m agreement to develop COVID-19 treatments

14-Sep-2021 By Jenni Spinner

The pharma tech firm has forged a four-year partnership with the foundation to develop antivirals for COVID-19 and other viruses with pandemic potential.

NIH offers $185m to further understanding of the human genome

13-Sep-2021 By Jenni Spinner

The US medical research agency plans to offer funding over five years through a newly launched consortium, expected to include 30 sites across the country.

Recent FDA COVID-19 actions and updates

10-Sep-2021 By Jenni Spinner

The US agency continues to oversee vaccine and drug development, and to share information and advice for life-sciences professionals and civilians alike.

Neuroglee, Mayo Clinic partner on remote care management for Alzheimer’s

09-Sep-2021 By Jenni Spinner

The digital therapeutics firm's Neuroglee Connect remote care platform and virtual clinic is for patients with mild cognitive impairment, including Alzheimer’s.

Biomarker panel to elevate prostate cancer diagnostics: Berg

07-Sep-2021 By Jenni Spinner

The clinical-stage biotech firm and a number of high-profile partners have collaborated on biomarker technology to deliver a more accurate, less invasive option.

People on the Move: September 2021

02-Sep-2021 By Jenni Spinner

This month’s news on new hires, board launches, acquisitions, and other important news includes items on Pfizer, Javara, Clinical Ink, and other companies.

Survey: cancer patients missing out on much-needed genetic testing

31-Aug-2021 By Jenni Spinner

According to patient-matching specialist TrialJectory, 90% of cancer patients know the vitality of genetic testing but more than half are not being tested.

Partnership fights to amplify Black women’s voice in breast cancer research

31-Aug-2021 By Jenni Spinner

The #BlackDataMatters movement aims to improve outcomes for Black women living with breast cancer by increasing their presence in vital clinical research.

Merck to collaborate with Ontada on data-driven cancer insights

26-Aug-2021 By Jenni Spinner

Merck (known as MSD outside the US and Canada) will partner with the data insights firm on solutions that progress real-world research and innovations.

Cloud lab solution empowers access of research tech from miles away

26-Aug-2021 By Jenni Spinner

Emerald Cloud Lab’s remote, automated laboratory technology puts pieces of advanced scientific equipment within the reach of smaller research outfits.

MMS support program to help ultra-rare disease research

24-Aug-2021 By Emily Jarecki

The CRO has launched an initiative that offers help navigating regulatory issues for ultra-rare disease patient advocacy groups that demonstrate a need.

Insilico Medicine uses AI to uncover preclinical candidate for kidney fibrosis

23-Aug-2021 By Jenni Spinner

The drug discovery company reportedly used AI-powered drug discovery to come up with a promising preclinical candidate for treatment of the kidney ailment.

Datavant, Real Chemistry form precision medicine partnership

23-Aug-2021 By Jenni Spinner

The two firms will work together on solutions to connect de-identified, first-party data to real-world data to help advance precision medicine development.

Paige, Perspectum forge AI-centered clinical trial alliance

19-Aug-2021 By Emily Jarecki

The digital pathology firm and image-analysis software developer will partner on artificial intelligence based solutions to improve trial decision making.

Trialbee partners with specialized CRO to accelerate precision medicine development

19-Aug-2021 By Jenni Spinner

The patient matching platform firm will work with Precision for Medicine on solutions to increase diversity, elevate enrollment and speed new therapies.

Trial complexity, info explosion driving data management evolution

17-Aug-2021 By Jenni Spinner

A leader from Veeva Systems shares perspective on what factors are impacting clinical trial data management, and how the industry can adapt to the changes.

Alzheimer’s research tool targets underrepresented groups

16-Aug-2021 By Emily Jarecki

The National Institute on Aging has launched Outreach Pro, an online tool aimed to help connect with underrepresented populations for Alzheimer’s trials.

Study examines long-term effects of COVID-19 on athletes' hearts

12-Aug-2021 By Jenni Spinner

The Heart of Athletes study, using Deloitte’s ConvergeHealth MyPath for Clinical platform, aims to examine heart inflammation in athletes with the virus.

Current FDA COVID-19 related actions and advice

11-Aug-2021 By Jenni Spinner

The US Food and Drug Administration has kept its staff busy with approvals, authorizations, and warnings related to various coronavirus-centered products.

BMS joins with Black colleges to increase pharma talent diversity

10-Aug-2021 By Jenni Spinner

The pharma firm is working with five US colleges and universities onto create programming designed to boost recruitment of Black talent in the industry

UIC studying IV drug as potential COVID-19 treatment

10-Aug-2021 By Emily Jarecki

The University of Illinois at Chicago has been given $6m from the US Department of Defense to develop a potential treatment for severe cases of COVID-19.

Virtual reality technology transforming COVID-19 drug discovery

09-Aug-2021 By Jenni Spinner

Nanome’s virtual reality tech is being put to use by Oak Ridge National Laboratory and top pharma firms to study COVID-19 and explore drug candidates.

Artificial intelligence stands to ‘revolutionize’ research: Bioclinica

05-Aug-2021 By Jenni Spinner

A leader from the clinical research tech specialist explains how the use of AI is increasing and outlines the many ways it could change the field.

Psychedelics research institute launches in Australia

03-Aug-2021 By Jenni Spinner

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

AstraZeneca, Regeneron join on obesity drug discovery

29-Jul-2021 By Jenni Spinner

The two companies are collaborating to research, develop and launch new small-molecule drug candidates aimed at treating obesity and related comorbidities.

New eLearning program aimed at enabling faster clinical adoption and improving patient access to ATMPs

26-Jul-2021 By Jane Byrne

A new UK eLearning program is targeted at healthcare and academic professionals to support their learning on advanced therapy medicinal products (ATMPs).

Next-level tech elevates clinical data management: AiCure

22-Jul-2021 By Jenni Spinner

A leader from the artificial intelligence solutions firm discusses how advanced analytical tools can help researchers make the most of mountains of data.